Five Best Biotech Stocks To Invest in Before 2022 Ends

In this video, we take a look at the five vest biotech stocks to invest in before 2022 ends. The stocks mentioned in this video are Soligenix (SNGX stock), Enlivex Therapeutics (ENLV stock), Incyte Corporation (INCY stock), I-Mab (IMAb stock), and Intellia Therapeutics (NTLA stock).

The opportunity found in the domain of biotech stocks is unlike that in any other economic industry. These companies typically are not in their profitable phases and allocate resources primarily toward the development of promising drugs on the path to commercialization. These early strategic bets on such stocks can deliver a substantial pay-off, especially for those that take on a calculated risk-reward assessment. Those that play their cards right could see their portfolios magnify in the short term, given the approaching price catalysts that many biotech stocks are faced with. Each of the stocks mentioned in this video holds a number of core strengths, making them ideal to bet on for investors.
_____________________________________________________
_____________________________________________________
▬ Chapters ▬

0:00 - intro
1:18 - Soligenix (SNGX stock)
3:10 - Enlivex Therapeutics (ENLV stock)
5:30 - Incyte Corporation (INCY stock)
7:32 - I-Mab (IMAb stock)
9:30 - Intellia Therapeutics (NTLA stock)
_________________________________________________________

______________________________________________________________
Disclaimer : The videos on this channel do not provide any personal recommendations or investment advice to subscribers. There are significant risks associated with investing. There are no guarantees provided by the authors, publishers, or any affiliates of their respective companies regarding the results of using the videos.

The creator of Video Content has gathered information from trustworthy sources. This video is intended only for educational purposes. Although Stocks Telegraph strives to ensure the content of this video is accurate and up-to-date, all information included in this video is presented as-is.

It is advisable not to rely on the information in this video when making investment decisions. There is a chance that the stocks mentioned in this video are owned by the owner/operator of this channel, which may impact our ability to remain unbiased. Investing decisions should be made with the help of a financial advisor.
#biotech #stocks #investing